Home » Critical Pharmaceuticals Announces Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone
Critical Pharmaceuticals Announces Successful Completion of Second Clinical Trial on CP024 Intranasal Growth Hormone
Critical Pharmaceuticals today announced that it has successfully completed a second clinical study on its CP024 growth hormone nasal spray.
PipelineReview
PipelineReview
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May